Viemed Healthcare (NASDAQ:VMD) Rating Increased to Hold at Zacks Research

Zacks Research upgraded shares of Viemed Healthcare (NASDAQ:VMD) to a hold rating in a research report released on Thursday morning,Zacks.com reports.

Several other equities analysts also recently commented on VMD. Weiss Ratings restated a “hold (c)” rating on shares of Viemed Healthcare in a research note on Monday, December 29th. Wall Street Zen lowered shares of Viemed Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Two research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the stock has a consensus rating of “Hold”.

Viemed Healthcare Price Performance

Shares of NASDAQ VMD opened at $7.24 on Thursday. The firm has a market cap of $275.26 million, a P/E ratio of 21.94 and a beta of 1.25. The business’s 50 day moving average is $6.94 and its 200-day moving average is $6.85. The company has a current ratio of 1.13, a quick ratio of 1.01 and a debt-to-equity ratio of 0.14. Viemed Healthcare has a 1-year low of $5.93 and a 1-year high of $8.61.

Viemed Healthcare (NASDAQ:VMD) last released its quarterly earnings results on Wednesday, November 5th. The company reported $0.09 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.09. The business had revenue of $71.91 million during the quarter, compared to the consensus estimate of $72.00 million. Viemed Healthcare had a return on equity of 9.95% and a net margin of 5.34%.

Institutional Investors Weigh In On Viemed Healthcare

Large investors have recently bought and sold shares of the company. Quarry LP acquired a new position in shares of Viemed Healthcare in the 3rd quarter valued at approximately $48,000. AQR Capital Management LLC acquired a new position in Viemed Healthcare during the first quarter valued at approximately $90,000. SG Americas Securities LLC bought a new stake in Viemed Healthcare during the fourth quarter worth $101,000. Cardinal Point Capital Management ULC acquired a new stake in shares of Viemed Healthcare in the 2nd quarter valued at $128,000. Finally, Intech Investment Management LLC increased its stake in shares of Viemed Healthcare by 14.4% in the 2nd quarter. Intech Investment Management LLC now owns 18,612 shares of the company’s stock valued at $129,000 after purchasing an additional 2,349 shares during the last quarter. 74.24% of the stock is currently owned by institutional investors and hedge funds.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.